Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Keystone

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Clinical and Translational Science|January 27, 2021
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjectsKyung-Sang Yu, In-Jin Jang, Hyeong-Seok Lim, et al.
Medicine|July 19, 2016
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trialRu Li, Jin-Xia Zhao, Yin Su, et al.
Annals of the Rheumatic Diseases|February 5, 2011
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsDavid T Felson, Josef S Smolen, George Wells, et al.
Arthritis and Rheumatism|February 5, 2011
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsDavid T Felson, Josef S Smolen, George Wells, et al.
Nature Genetics|November 5, 2022
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritisKazuyoshi Ishigaki, Saori Sakaue, Chikashi Terao, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Clinical and Translational Science|January 27, 2021
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjectsKyung-Sang Yu, In-Jin Jang, Hyeong-Seok Lim, et al.
Medicine|July 19, 2016
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trialRu Li, Jin-Xia Zhao, Yin Su, et al.
Annals of the Rheumatic Diseases|February 5, 2011
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsDavid T Felson, Josef S Smolen, George Wells, et al.
Arthritis and Rheumatism|February 5, 2011
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsDavid T Felson, Josef S Smolen, George Wells, et al.
Nature Genetics|November 5, 2022
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritisKazuyoshi Ishigaki, Saori Sakaue, Chikashi Terao, et al.
Pageof 9